Preparation and cellular uptake of PLGA particles loaded with lamivudine

Chinese Science Bulletin

Volumn 57, Issue 31, 2012, Pages 3985-3993

  Wang, Bing ^a   Chen, GuanQun ^a   Mao, ZhengWei ^a   Zhang, YuYing ^a   Yu, DaHai ^a   Gao, ChangYou ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

cell uptake; drug delivery; intracellular distribution; lamivudine; PLGA

Indexed keywords

BOVINAE;

EID: 84868202092     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1007/s11434-012-5419-1     Document Type: Article

References (34)

1. Hildt E, Hofschneider P H, Urban S. The role of hepatitis B virus (HBV) in the development of hepatocellular carcinoma. Semin Virol, 1996, 7: 333-347.
2. Lai C L, Ratziu V, Yuen M F, et al. Viral hepatitis B. Lancet, 2003, 362: 2089-2094.
3. Ye L, Zhang Y, Mei Y, et al. Detecting putative recombination events of hepatitis B virus: An updated comparative genome analysis. Chin Sci Bull, 2010, 55: 2373-2379.
4. Doong S L, Tsai C H, Schinazi R F. Inhibition of the replication of hepatitis B virus in vitro by 2′, 3′-dideoxy-3′-thiacytidine and related analogues. Proc Natl Acad Sci USA, 1991, 88: 8495-8499.
5. Bartholomew M M, Jansen R W, Jeffers L J. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet, 1997, 349: 20-22.
6. Fox Z, Dragsted U B, Gerstoft J. A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: The COLATE trial. Antivir Ther, 2006, 11: 761-770.
7. Kuo Y C, Chen H H. Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood-brain barrier. Int J Pharm, 2006, 327: 160-169.
8. Li Q, Du Y Z, Yuan H. Synthesis of lamivudine stearate and antiviral activity of stearic acid-g-chitosan oligosaccharide polymeric micelles delivery system. Eur J Pharm Sci, 2010, 41: 498-507.
9. Chimalakonda K C, Agarwal H K, Kumar A. Synthesis, analysis, in vitro characterization, and in vivo disposition of a lamivudine-dextran conjugate for selective antiviral delivery to the liver. Bioconj Chem, 2007, 18: 2097-2108.
10. Dutta T, Jain N K. Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly(propyleneimine) dendrimer. BBA-General Subjects, 2007, 1770: 681-686.
11. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliver Rev, 2003, 55: 329-347.
12. 2 particles on adhesion and migration of HepG2 cells. Acta Polym Sin, 2009, 815-822.
13. Brannon-Peppas L, Blanchette J O. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliver Rev, 2004, 56: 1649-1659.
14. Hu L, Zhang Y, Gao C. Influence of structures and properties of polymer nanoparticles on their cellular uptake and cell functions. Prog Chem, 2009, 21: 1254-1267.
15. Yang H, Miyoshi H, Lou C, et al. Preparation, characterization and release of methyl viologen from a novel nanoparticle delivery system with double shells of silica and PLGA. Chin Sci Bull, 2010, 55: 263-267.
16. Faisant N, Akiki J, Siepmann F. Effect of the type of release medium on drug release from PLGA-based microparticles: Experiment and theory. Int J Pharm, 2006, 314: 189-197.
17. Siepmann J, Faisant N, Akiki J. Effect of the size of biodegradable microparticles on drug release: Experiment and theory. J Control Release, 2004, 96: 123-134.
18. Hu L, Mao Z, Gao C. Colloidal particles for cellular uptake and delivery. J Mater Chem, 2009, 19: 3108-3115.
19. Mundargi R C, Babu V R, Vidhya R. Nano/micro technologies for delivering macromolecular therapeutics using poly(D, L-lactide-co-glycolide) and its derivatives. J Control Release, 2008, 125: 193-209.
20. Cu Y, LeMoellic C, Caplan M J. Ligand-modified gene carriers increased uptake in target cells but reduced DNA release and transfection efficiency. Nanomed: Nanotechnol Biol Med, 2009, 6: 1-10.
21. Zhou S, Sun J, Sun L. Preparation and characterization of interferon-loaded magnetic biodegradable microspheres. J Biomed Mater Res B, 2008, 87B: 190-195.
22. Zambaux M F. Preparation and characterization of protein C-loaded PLA nanoparticles. J Control Release, 1999, 60: 179-188.
23. Gorner T, Gref R, Michenot D. Lidocaine-loaded biodegradable nanospheres. I. Optimization of the drug incorporation into the polymer matrix. J Control Release, 1999, 57: 259-268.
24. Zhou J, Moya S, Gao C. Folic acid modified poly(lactide-co-glycolide) nanoparticles, layer-by-layer surface engineered for targeted delivery. Macromol Chem Phys, 2010, 211: 404-411.
25. Zhou J, Moya S, Gao C. Layer by layer chitosan/alginate coatings on poly(lactide-co-glycolide) nanoparticles for antifouling protection and Folic acid binding to achieve selective cell targeting. J Colloid Interf Sci, 2010, 345: 241-247.
26. Zhou J, Moya S, Gao C. Polyelectrolyte coated PLGA nanoparticles: Templation and release behavior. Macromol Biosci, 2009, 9: 326-335.
27. Bilati U, Mann E A, Doelker E. Poly(D, L-lactide-co-glycolide) protein-loaded nanoparticlesprepared by the double emulsion method-Processing and formulation issues for enhanced entrapment efficiency. J Microencapsul, 2005, 22: 205-214.
28. Xie L, Tong W, Xu J, et al. Multilayers and poly(allylamine hydro chloride)-graft-poly(ethylene glycol) modified bovine serum albumin nanoparticles: Improved stability and pH-responsive drug delivery. Chin J Polym Sci, 2012, 30: 719-726.
29. Feng Z, Gao C, Shen J. Fabrication and characterization of gold nanoparticles loaded microcapsules. Acta Polym Sin, 2008, 8: 823-827.
30. Li J, Li L, Cao H. Establishment of highly differentiated immortalized human hepatocyte line with simian virus 40 large tumor antigen for liver based cell therapy. ASAIO J, 2005, 51: 261-268.
31. Bilati U, Allemann E, Doelke E. Sonication parameters for the preparation of biodegradable nanocapsules of controlled size by the double emulsion method. Pharm Dev Technol, 2003, 8: 1-9.
32. Chung T H, Wu S, Yao M. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials, 2007, 28: 2959-2966.
33. Zhang Y, Hu L, Yu D, et al. Influence of silica particle internalization on adhesion and migration of human dermal fibroblasts. Biomaterials, 2010, 31: 8465-8474.
34. Hillaireau H, Couvreur P. Nanocarriers' entry into the cell: Relevance to drug delivery. Cell Mol Life Sci, 2009, 66: 2873-2896.